Skip navigation

Chemical Linagliptin

Name Linagliptin
Equivalent Terms 1356, BI | 1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)- | BI1356 | BI 1356 | BI-1356 | (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione | Tradjenta | Trajenta
Definition A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.
Top Interacting
Genes
MeSH® ID D000069476
External Links

Top ↑ Ancestors

1. ChemicalsHeterocyclic Compounds Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Heterocyclic Compounds, Fused-Ring Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Heterocyclic Compounds, 2-Ring Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Purines Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Linagliptin Has associated genes Has associated diseases Has associated phenotype references
2. ChemicalsHeterocyclic Compounds Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Heterocyclic Compounds, Fused-Ring Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Heterocyclic Compounds, 2-Ring Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Quinazolines Has associated genes Has associated diseases Has associated phenotype references Linagliptin Has associated genes Has associated diseases Has associated phenotype references

Top ↑ Descendants

None.